Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing sarcoma

Bartimée Galvan, Loïc Ongena, Jonathan Bruyr, Gregory Fettweis, Eva Lucarelli, Arnaud Lavergne, Emeline Mariavelle, Tina M. O’Grady, Zahrat El Oula Hassoun, Margaux Claes, Laurence Dubois, Kevin A. W. Lee, Véronique Kruys, Cyril Gueydan, Jules Durand, Eric Hervouet, Florian H. Geyer, Ana Banito, Roland Imle, Lianghao Mao, Ashok K. Jayavelu, Thomas G. P. Grünewald, Florencia Cidre-Aranaz, Jean-Claude Twizere, Franck Dequiedt

Open source

DOI: 10.1038/s41467-025-61725-x
Published: 2025-07-16
Container: Nature Communications
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-025-61725-x,
  title = {Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing sarcoma},
  author = {Bartimée Galvan and Loïc Ongena and Jonathan Bruyr and Gregory Fettweis and Eva Lucarelli and Arnaud Lavergne and Emeline Mariavelle and Tina M. O’Grady and Zahrat El Oula Hassoun and Margaux Claes and Laurence Dubois and Kevin A. W. Lee and Véronique Kruys and Cyril Gueydan and Jules Durand and Eric Hervouet and Florian H. Geyer and Ana Banito and Roland Imle and Lianghao Mao and Ashok K. Jayavelu and Thomas G. P. Grünewald and Florencia Cidre-Aranaz and Jean-Claude Twizere and Franck Dequiedt},
  year = {2025},
  journal = {Nature Communications},
  doi = {10.1038/s41467-025-61725-x},
  url = {https://doi.org/10.1038/s41467-025-61725-x}
}

RIS

TY  - JOUR
TI  - Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing sarcoma
AU  - Bartimée Galvan
AU  - Loïc Ongena
AU  - Jonathan Bruyr
AU  - Gregory Fettweis
AU  - Eva Lucarelli
AU  - Arnaud Lavergne
AU  - Emeline Mariavelle
AU  - Tina M. O’Grady
AU  - Zahrat El Oula Hassoun
AU  - Margaux Claes
AU  - Laurence Dubois
AU  - Kevin A. W. Lee
AU  - Véronique Kruys
AU  - Cyril Gueydan
AU  - Jules Durand
AU  - Eric Hervouet
AU  - Florian H. Geyer
AU  - Ana Banito
AU  - Roland Imle
AU  - Lianghao Mao
AU  - Ashok K. Jayavelu
AU  - Thomas G. P. Grünewald
AU  - Florencia Cidre-Aranaz
AU  - Jean-Claude Twizere
AU  - Franck Dequiedt
PY  - 2025
JO  - Nature Communications
DO  - 10.1038/s41467-025-61725-x
UR  - https://doi.org/10.1038/s41467-025-61725-x
ER  -

APA

Galvan, B., Ongena, L., Bruyr, J., Fettweis, G., Lucarelli, E., Lavergne, A., Mariavelle, E., O’Grady, T. M., Hassoun, Z. E. O., Claes, M., Dubois, L., Lee, K. A. W., Kruys, V., Gueydan, C., Durand, J., Hervouet, E., Geyer, F. H., Banito, A., Imle, R., Mao, L., Jayavelu, A. K., Grünewald, T. G. P., Cidre-Aranaz, F., Twizere, J., & Dequiedt, F. (2025). Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing sarcoma. Nature Communications. https://doi.org/10.1038/s41467-025-61725-x

Source records

crossref · retrieved 2026-09-27T05:05:07.321Z